Omeros to Present at the Cantor Virtual Global Healthcare Conference
September 11 2020 - 6:00AM
Business Wire
Omeros Corporation (Nasdaq: OMER) today announced that Gregory
A. Demopulos, M.D., chairman and chief executive officer, will
present at the Cantor Virtual Global Healthcare Conference next
week. The presentation is scheduled for Tuesday, September 15, 2020
at 11:20 a.m. EDT.
The presentation will be webcast. The live and archived webcasts
can be accessed on the investor relations section of the company’s
website at www.omeros.com under “Events.”
About Omeros Corporation Omeros is a commercial-stage
biopharmaceutical company committed to discovering, developing and
commercializing small-molecule and protein therapeutics for
large-market and orphan indications targeting inflammation,
complement-mediated diseases, disorders of the central nervous
system and immune-related diseases, including cancers. In addition
to its commercial product OMIDRIA (phenylephrine and ketorolac
intraocular solution) 1%/0.3%, Omeros has multiple late-stage
clinical development programs focused on complement-mediated
disorders, including COVID-19, and substance abuse. A rolling
biologics license application for narsoplimab, the company’s lead
MASP-2 inhibitor, in hematopoietic stem cell transplant-associated
thrombotic microangiopathy is being completed for submission to the
U.S. FDA. Omeros also has a diverse group of preclinical programs
including GPR174, a novel target in immuno-oncology that modulates
a new cancer immunity axis recently discovered by Omeros.
Small-molecule inhibitors of GPR174 are part of Omeros’ proprietary
G protein-coupled receptor (GPCR) platform through which it
controls 54 new GPCR drug targets and their corresponding
compounds. The company also exclusively possesses a novel
antibody-generating platform.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200911005106/en/
Jennifer Cook Williams Cook Williams Communications, Inc.
Investor and Media Relations 360.668.3701 jennifer@cwcomm.org
Omeros (NASDAQ:OMER)
Historical Stock Chart
From Mar 2024 to Apr 2024
Omeros (NASDAQ:OMER)
Historical Stock Chart
From Apr 2023 to Apr 2024